OakChart

United-Guardian Inc

UGConsumer Defensive·Household & Personal Products·USA·Nano·NASD·Nov 12 • 3:59 PM ET

8.63+0.04 (0.47%)
2026-11-13 13:49 CET
Market cap
$39.65M
Revenue, TTM
12.44 USD m
Net income, TTM
3.13 USD m
Free cash flow, TTM
2.94 USD m
EPS diluted, TTM
0.68
Price / earnings
12.68
Compare

Price

UG against its 20, 50 and 200-day averages
Terms2050200
Patternshover a marker to name it
RS 67.008.009.0010.0044K87KVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26UGclose 8.6320-day 7.2050-day 7.15200-day 7.018.6352w high 9.9552-week range, not 6 months

13.3% under the 52-week high of 9.95 on 10 Nov 2026. 52-week low 5.58 on 25 Nov 2025. Last 15 sessions, 50.8% high to low

Volume 0.00× normal · the session has not printed · the line is the 50-bar volume average

Setup. RS line 6
CANSLIM 1 of 6 — fails: 52-Week High/Low: 0-10% below High; Performance: Year +50%; Institutional Ownership: Over 50%; Average Volume: Over 200K — not on the tape: EPS Growth This Year: High (>25%)
VCP 4 of 6 — fails: 52-Week High/Low: 0-10% below High; RSI (14): Not Overbought (<60)
Minervini 2 of 4 — fails: 52-Week High/Low: 0-10% below High; Performance: Year +50%
Zanger 3 of 5 — fails: 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5
Leaders 2 of 5 — fails: Performance: Year +50%; Average Volume: Over 500K; 52-Week High/Low: 0-10% below High
Breakout 2 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2
Growth 2 of 4 — not on the tape: EPS Growth This Year: High (>25%); EPS Growth Next Year: High (>25%)
Quality 5 of 5
Value 3 of 4 — fails: P/B: Under 2
Income 2 of 4 — fails: Dividend Growth: Growing 2+ Years; Payout Ratio: Low (<20%)
Small Cap 2 of 4 — fails: Average Volume: Over 500K; Performance: Year +50%
Accumulation 2 of 4 — fails: Institutional Ownership: Over 30%; Institutional Transactions: Over +10%
Relative Strength 1 of 3 — fails: Performance: Year +100%; Average Volume: Over 500K

Profile

UG
52-week range, 70% of the way up
5.589.95

United-Guardian, Inc. engages in the development and manufacture of pharmaceuticals, cosmetic ingredients, personal and health care products and medical devices. It also conducts research and product development related to the development of new and unique cosmetic and personal care products. The company was founded by Alfred R. Globus in 1942 and is headquartered in Hauppauge, NY.

Employees25
IPOMar 17, 1980
Beta1.00
ATR, 14d0.54
Rel volume0.00
Short float0.29%
Insider own35.65%
Inst own19.20%

Snapshot

6 groups

Valuation

Index-
Market Cap$39.65M
Enterprise Value30.91M
Income3.13M
Sales12.44M
Book / share2.43
Cash / share1.90
Dividend Est.-
Dividend TTM0.55 (6.37%)
Dividend Ex-DateJul 28, 2026
Dividend Gr. 3/5Y-4.09% -5.11%
Payout130.92%
Employees25
IPOMar 17, 1980

Ratios

Price / earnings12.68
Forward price / earnings-
Price / earnings / growth-
Price / sales3.19
Price / book3.55
Price / cash4.54
Price / free cash flow13.49
Value / cash profit9.25
Value / sales2.48
Quick Ratio5.92
Current Ratio6.50
Debt / equity0.00
Long-term debt / equity0.00
Options and shortNo / Yes

Earnings

Earnings / share0.68
Earnings next year-
Earnings next quarter-
Earnings this year-
Earnings next year-
Earnings growth, 5 years-
Past earnings growth-6.42% -8.62%
Past sales growth-6.01% -0.82%
Earnings vs last year59.59%
Sales vs last year23.63%
Earnings vs last quarter246.92%
Sales vs last quarter54.35%
Earnings-
Surprise- -

Ownership

Insiders own35.65%
Insider trades0.00%
Institutions own19.20%
Institution trades-0.40%
Return on assets24.41%
Return on equity28.74%
Return on capital27.97%
Gross Margin49.43%
Operating margin25.95%
Profit Margin25.15%
20-day average19.79%
50-day average20.77%
200-day average23.14%

Technical

Shares out4.59M
Shares floating2.96M
Short / float0.29%
Short ratio0.66
Short interest0.01M
52-week high9.95 -13.3%
52-week low5.58 +54.8%
Volatility10.73% 5.66%
Average range0.54
Strength index68.27
Market sensitivity1.00
Relative volume0.00
Avg Volume13.00K
Volume0

Performance

Perf Week26.91%
Perf Month23.82%
Perf Quarter20.70%
Perf Half Y20.36%
Perf YTD40.10%
Perf Year40.55%
Perf 3Y21.65%
Perf 5Y-39.20%
Perf 10Y-44.90%
Recommendation-
Target Price-
Prev Close8.63
Price8.63
Change %0.00%

Peers

Mkt cap
TickerCompanyMkt cap
SLSNSolesence Inc83.37M
SKINSkinHealth Systems Inc104.42M
ACUAcme United Corp278.62M
ASHAshland Inc3.45B
IOSPInnospec Inc1.96B
SXTSensient Technologies Corp4.92B
LFCRLifecore Biomedical Inc242.60M
BCPCBalchem Corp5.48B
PBHPrestige Consumer Healthcare Inc2.15B
NTICNorthern Technologies International Corp73.60M

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 696.31B
DFMCU.S. Micro Cap Portfolio ETF Class SharesAUM: 213.58M
VXFVanguard Extended Market Index ETFAUM: 30.79B
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.64B
IWCiShares Micro-Cap ETFAUM: 1.23B
BUSMEA Bridgeway Ultra-Small Company Market ETFAUM: 112.81M
DFACU.S. Core Equity 2 Portfolio-ETF Class SharesAUM: 49.67B
DCORUS Core Equity 1 Portfolio ETF Class SharesAUM: 3.69B
DFSUDimensional US Sustainability Core 1 ETFAUM: 2.40B
DXUVUS Vector Equity Portfolio ETF Class SharesAUM: 671.26M

News

latest 14 of 200

Quarterly earnings

2026Q1 sales 2.87, from 2.48 a year earlier
Sales, USD millions
3.3902023Q3 sales 3.0623Q32024Q1 sales 3.2524Q12024Q2 sales 3.3924Q22024Q3 sales 3.0624Q32025Q1 sales 2.4825Q12025Q2 sales 2.8425Q22025Q3 sales 2.2625Q32026Q1 sales 2.8726Q1

The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.

PeriodReportedEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mSurpriseYear-ago quarterAnalystsNext session
2026Q1ended 2026-03-312026-05-08 08:30--0.1782.87-EPS - · sales -vs 2025Q1, year-ago quarter · EPS - · sales +15.8%-Open +1.57% vs SPY +0.46%. Close -1.86% vs SPY +0.83%
2025Q3ended 2025-09-302025-11-06 08:30--0.0582.26-EPS - · sales -vs 2024Q3, year-ago quarter · EPS - · sales -26.0%-Open -1.86% vs SPY -0.16%. Close -6.29% vs SPY -1.07%
2025Q2ended 2025-06-302025-08-08 08:30--0.1362.84-EPS - · sales -vs 2024Q2, year-ago quarter · EPS - · sales -16.3%-Open 0.00% vs SPY +0.29%. Close -0.50% vs SPY +0.78%
2025Q1ended 2025-03-312025-05-08 08:30--0.1222.48-EPS - · sales -vs 2024Q1, year-ago quarter · EPS - · sales -23.8%-Open -0.37% vs SPY +0.73%. Close +0.61% vs SPY +0.70%
2024Q3ended 2024-09-302024-11-08 08:30--0.1883.06-EPS - · sales -vs 2023Q3, year-ago quarter · EPS - · sales +0.1%-Open +1.87% vs SPY +0.09%. Close -12.06% vs SPY +0.43%
2024Q2ended 2024-06-302024-08-09 08:30--0.2083.39-EPS - · sales -vs 2023Q2, year-ago quarter · EPS - · sales +27.9%-Open -0.36% vs SPY -0.16%. Close -1.97% vs SPY +0.44%
2024Q1ended 2024-03-312024-05-10 12:00--0.2013.25-EPS - · sales -vs 2023Q1, year-ago quarter · EPS - · sales +26.6%-Open 0.00% vs SPY +0.32%. Close +5.63% vs SPY +0.13%
2023Q3ended 2023-09-302023-11-06 08:30--0.1363.06-EPS - · sales -vs 2022Q3, year-ago quarter · EPS - · sales +26.5%-Open +6.56% vs SPY +0.18%. Close +27.81% vs SPY +0.23%
2023Q2ended 2023-06-302023-08-11 08:30--0.1002.65-EPS - · sales -vs 2022Q2, year-ago quarter · EPS - · sales -26.9%-Open +0.28% vs SPY -0.44%. Close -0.74% vs SPY -0.06%
2023Q1ended 2023-03-312023-05-11 12:00--0.1652.57-EPS - · sales -vs 2022Q1, year-ago quarter · EPS - · sales -34.0%-Open -0.13% vs SPY -0.22%. Close -2.73% vs SPY -0.17%
2022Q3ended 2022-09-302022-11-09 08:30--0.0752.42-EPS - · sales -vs 2021Q3, year-ago quarter · EPS - · sales -24.0%-Open -1.44% vs SPY -0.54%. Close -5.93% vs SPY -2.06%
2022Q2ended 2022-06-302022-08-12 12:00--0.1383.63-EPS - · sales -vs 2021Q2, year-ago quarter · EPS - · sales -0.9%-Open +1.29% vs SPY +0.49%. Close -4.44% vs SPY +1.69%
2022Q1ended 2022-03-312022-05-12 08:30--0.1983.89-EPS - · sales -vs 2021Q1, year-ago quarter · EPS - · sales +13.5%--
2021Q3ended 2021-09-302021-11-10 08:30--0.2213.18-EPS - · sales -vs 2020Q3, year-ago quarter · EPS - · sales +36.1%--
2021Q2ended 2021-06-302021-08-11 08:30--0.2933.66-EPS - · sales -vs 2020Q2, year-ago quarter · EPS - · sales +23.8%--
2021Q1ended 2021-03-312021-05-12 08:30--0.2573.43-EPS - · sales -vs 2020Q1, year-ago quarter · EPS - · sales +3.2%--

Annual earnings

2013FY EPS 1.280, from 1.050 a year earlier. Sales 15.42, from 13.83 a year earlier
EPS
1.28002010FY EPS 0.80020102011FY EPS 1.030 against 0.93020112012FY EPS 1.05020122013FY EPS 1.2802013
Sales, USD millions
15.4202010FY sales 13.7220102011FY sales 14.3420112012FY sales 13.8320122013FY sales 15.422013

Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.

earnings feed, not the snapshot. Not the statement ratio.

PeriodEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mP/E, earnings feed
2013FY1.280-1.28015.42-6.74
2012FY1.050-1.05013.83-8.22
2011FY1.0300.9301.03014.34-8.38
2010FY0.800-0.80013.72-10.79

Quarterly results

2026Q3 revenue 3.49, from 2.26 a year earlier. Operating margin 31.8%, from 9.7% a year earlier
Revenue, USD millions
3.4902024Q4 revenue 2.4824Q42025Q1 revenue 2.4825Q12025Q2 revenue 2.8425Q22025Q3 revenue 2.2625Q32025Q4 revenue 2.9625Q42026Q1 revenue 2.8726Q12026Q2 revenue 3.1126Q22026Q3 revenue 3.4926Q3
Operating margin
31.802024Q4 operating margin 22.6%24Q42025Q1 operating margin 24.6%25Q12025Q2 operating margin 24.6%25Q22025Q3 operating margin 9.7%25Q32025Q4 operating margin 24.3%25Q42026Q1 operating margin 22.3%26Q12026Q2 operating margin 24.1%26Q22026Q3 operating margin 31.8%26Q3

From the quarterly statement. Not an estimate.

Estimate revisions

Latest snapshot of each period and type.

No estimate revisions.

Estimate history

Annual
Metric201720182019202020212022202320242025TTMMRQ
EPS per share0.8370.9471.0360.7191.0140.5590.5620.7080.4580.6808-
Sales USD millions13131411141311121112-
Shares million shares555555555-5
Quarterly
MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
EPS per share0.1880.110.1220.1360.0580.1410.1780.1590.203
Sales USD millions322323333
Shares million shares555555555

Income statement, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/2018
Total Revenue12.4410.55-13.4%12.18+11.8%10.89-14.3%12.70-8.8%13.93+26.8%10.99-19.2%13.60+1.1%13.45
Cost of Goods Sold Incl. D&A6.295.51-3.7%5.72+4.4%5.48-8.7%6.00+4.3%5.75+18.1%4.87-14.0%5.66+6.0%5.34
Gross Profit6.155.03-22.1%6.46+19.4%5.41-19.3%6.70-18.1%8.18+33.9%6.11-23.0%7.94-2.0%8.10
Selling, General and Administrative Excl. Other2.922.79-0.7%2.81+10.6%2.54-4.5%2.66+6.0%2.51+1.2%2.48-2.7%2.55+1.2%2.52
Research and Development0.450.36-21.7%0.460.0%0.46-6.1%0.49+2.1%0.48+6.7%0.45+12.5%0.400.0%0.40
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income3.232.24-38.6%3.65+27.6%2.86-29.2%4.04-28.7%5.67+55.8%3.64-32.6%5.40-3.2%5.58
Interest Expense0.000.000.000.000.000.000.000.000.00
Unusual Expense-0.33-0.04-0.03-0.51-175.0%0.68+423.1%0.13+8.3%0.12-0.17-150.0%0.34
Net Income Before Taxes3.942.64-35.8%4.11+26.5%3.25+0.6%3.23-45.1%5.88+41.3%4.16-31.0%6.03+10.2%5.47
Income Taxes0.810.54-37.2%0.86+28.4%0.67+1.5%0.66-45.9%1.22+41.9%0.86-32.3%1.27+14.4%1.11
Consolidated Net Income3.132.11-35.1%3.25+26.0%2.58+0.4%2.57-44.8%4.66+41.2%3.30-30.7%4.76+9.4%4.35
Net Income From Continuing Operations3.132.11-35.1%3.25+26.0%2.58+0.4%2.57-44.8%4.66+41.2%3.30-30.7%4.76+9.4%4.35
Net Income3.132.11-35.1%3.25+26.0%2.58+0.4%2.57-44.8%4.66+41.2%3.30-30.7%4.76+9.4%4.35
EPS (Recurring) per share0.630.45-35.7%0.70+45.8%0.48-27.3%0.66-35.9%1.03+39.2%0.74-26.7%1.01+1.0%1.00
EPS (Basic, Before Extraordinaries) per share0.680.46-35.2%0.71+26.8%0.560.0%0.56-44.6%1.01+40.3%0.72-30.8%1.04+9.5%0.95
EPS (Diluted) per share0.680.46-35.2%0.71+26.8%0.560.0%0.56-44.6%1.01+40.3%0.72-30.8%1.04+9.5%0.95
EBITDA3.342.35-37.2%3.74+25.9%2.97-28.8%4.17-28.2%5.81+52.9%3.80-31.8%5.57-3.5%5.77
Non-Operating Income (Expense)0.380.36-16.3%0.43-0.13-0.13-137.1%0.35-45.3%0.64+36.2%0.47+113.6%0.22
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Price To Earnings Ratio ratio statement ratio, not the snapshot12.6812.6812.6013.1115.9516.2219.9918.9619.44
Price To Sales Ratio ratio2.642.683.613.043.785.436.016.646.27
Gross Margin %49.4347.7353.0349.6652.7858.7455.6558.4060.26
Operating Margin %25.9521.2729.9426.3031.7940.6833.1039.6841.50
Net Margin %25.1519.9726.6923.7120.2333.4430.0835.0132.37
Shares Outstanding million shares4.594.590.0%4.590.0%4.590.0%4.590.0%4.590.0%4.590.0%4.590.0%4.59
Market Capitalization39.6539.65-9.7%43.92+32.8%33.08-31.0%47.96-36.5%75.57+14.4%66.05-26.8%90.27+7.1%84.26

Income statement, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Total Revenue3.49+54.4%3.11+9.5%2.87+15.7%2.96+19.4%2.26-26.1%2.84-16.2%2.48-23.7%2.48-5.0%
Cost of Goods Sold Incl. D&A1.62+20.9%1.56+16.4%1.45+29.5%1.66+38.3%1.34-5.0%1.34-14.1%1.12-28.2%1.20-0.8%
Gross Profit1.88+102.2%1.55+3.3%1.42+4.4%1.30+1.6%0.93-43.6%1.50-18.0%1.36-20.0%1.28-8.6%
Selling, General and Administrative Excl. Other0.77+8.5%0.79-1.2%0.78+4.0%0.58-20.5%0.71+1.4%0.80+12.7%0.75+11.9%0.73+19.7%
Research and Development0.12+33.3%0.12+9.1%0.12+9.1%0.09-30.8%0.09-18.2%0.110.0%0.11+10.0%0.13+18.2%
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income1.11+404.5%0.75+7.1%0.64+4.9%0.72+28.6%0.22-76.8%0.70-36.9%0.61-40.8%0.56-29.1%
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense0.01-0.08-0.290.04-20.0%-0.04-0.02-300.0%-0.010.05
Net Income Before Taxes1.17+254.5%0.92+16.5%1.03+45.1%0.82+28.1%0.33-70.0%0.79-34.7%0.71-39.3%0.64-31.2%
Income Taxes0.24+300.0%0.19+18.8%0.21+40.0%0.17+21.4%0.06-73.9%0.16-36.0%0.15-37.5%0.14-26.3%
Consolidated Net Income0.93+244.4%0.73+15.9%0.82+46.4%0.65+30.0%0.27-69.0%0.63-34.4%0.56-39.8%0.50-32.4%
Net Income From Continuing Operations0.93+244.4%0.73+15.9%0.82+46.4%0.65+30.0%0.27-69.0%0.63-34.4%0.56-39.8%0.50-32.4%
Net Income0.93+244.4%0.73+15.9%0.82+46.4%0.65+30.0%0.27-69.0%0.63-34.4%0.56-39.8%0.50-32.4%
EPS (Recurring) per share0.20+300.0%0.15+15.4%0.13+8.3%0.15+25.0%0.05-72.2%0.13-38.1%0.12-40.0%0.12-25.0%
EPS (Basic, Before Extraordinaries) per share0.20+233.3%0.16+14.3%0.18+50.0%0.14+27.3%0.06-68.4%0.14-33.3%0.12-40.0%0.11-31.3%
EPS (Diluted) per share0.20+233.3%0.16+14.3%0.18+50.0%0.14+27.3%0.06-68.4%0.14-33.3%0.12-40.0%0.11-31.3%
EBITDA1.14+375.0%0.78+8.3%0.67+4.7%0.75+29.3%0.24-75.3%0.72-36.8%0.64-39.0%0.58-29.3%
Non-Operating Income (Expense)0.07-12.5%0.08+14.3%0.10+25.0%0.13-7.1%0.08-20.0%0.07-30.0%0.08-20.0%0.14+16.7%
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Price To Earnings Ratio ratio statement ratio, not the snapshot12.6813.8814.6214.4414.1212.7312.7012.60
Price To Sales Ratio ratio2.642.932.812.683.593.393.623.61
Gross Margin %53.6649.7349.5943.9640.8952.7654.7451.74
Operating Margin %31.7324.2622.3724.379.5024.5024.6222.46
Net Margin %26.6423.4428.5121.9311.8622.0922.6120.34
Shares Outstanding million shares4.590.0%4.590.0%4.590.0%4.590.0%4.590.0%4.590.0%4.590.0%4.590.0%
Market Capitalization39.65+9.8%32.80-10.7%30.78-25.5%28.30-35.6%36.11-50.5%36.75-10.5%41.30+17.5%43.92+32.8%

Balance sheet, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/20182017FY12/31/2017
Cash & Short Term Investments8.57-8.8%9.40+3.4%9.09+40.3%6.48-20.7%8.17-0.1%8.18+3.3%7.92-3.1%8.17-3.3%8.45
Short Term Receivables1.59+11.2%1.43-8.9%1.57+9.8%1.43-21.0%1.81+30.2%1.39-33.8%2.10+25.7%1.67-12.6%1.91
Inventories1.51+4.1%1.45+18.9%1.22-26.9%1.67+18.4%1.41-0.7%1.42+16.4%1.22-17.6%1.48+10.4%1.34
Other Current Assets0.53+35.9%0.39+5.4%0.37-5.1%0.39+105.3%0.19-26.9%0.26-23.5%0.34-5.6%0.36+125.0%0.16
Total Current Assets12.20-3.7%12.67+3.4%12.25+22.9%9.97-13.9%11.58+2.9%11.25-2.8%11.57-1.0%11.69-1.4%11.85
Net Property, Plant & Equipment0.91-5.2%0.96+54.8%0.62+10.7%0.56-15.2%0.66-1.5%0.67-14.1%0.78-6.0%0.83-11.7%0.94
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.000.000.000.000.00
Deferred Tax Assets0.35-42.6%0.61+24.5%0.49-2.0%0.50+13.6%0.44+46.7%0.30+15.4%0.260.0%0.26+52.9%0.17
Other Assets0.000.000.000.000.000.00-100.0%0.01-66.7%0.03-50.0%0.06
Total Assets13.46-5.4%14.23+6.5%13.36+21.1%11.03-13.0%12.68+3.8%12.22-3.2%12.63-1.4%12.81-1.6%13.02
Short Term Debt Incl. Current Port. of LT Debt0.000.000.000.000.000.000.000.000.00
Accounts Payable0.48+11.6%0.43+230.8%0.13+333.3%0.03-92.7%0.41+1266.7%0.03-57.1%0.07-63.2%0.19-45.7%0.35
Income Tax Payable---0.00-100.0%0.09--0.00-100.0%0.06
Other Current Liabilities1.19-20.1%1.49+6.4%1.40+4.5%1.34-27.2%1.84+33.3%1.38+8.7%1.27+7.6%1.18+16.8%1.01
Total Current Liabilities1.67-12.6%1.91+24.8%1.53+11.7%1.37-41.5%2.34+66.0%1.41+5.2%1.34-2.2%1.37-3.5%1.42
Long Term Debt0.000.000.000.000.000.000.000.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities0.56+27.3%0.440.0%0.44+12.8%0.39-25.0%0.52+15.6%0.45-30.8%0.65+25.0%0.52+147.6%0.21
Other Liabilities0.000.000.000.000.000.000.000.000.00
Total Liabilities2.23-5.1%2.35+19.3%1.97+11.9%1.76-38.5%2.86+52.9%1.87-6.0%1.99+5.9%1.88+15.3%1.63
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity11.23-5.5%11.88+4.3%11.39+22.9%9.27-5.6%9.82-5.1%10.35-2.6%10.63-2.7%10.92-4.2%11.40
Total Shareholders Equity11.23-5.5%11.88+4.3%11.39+22.9%9.27-5.6%9.82-5.1%10.35-2.6%10.63-2.7%10.92-4.2%11.40
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity11.23-5.5%11.88+4.3%11.39+22.9%9.27-5.6%9.82-5.1%10.35-2.6%10.63-2.7%10.92-4.2%11.40
Total Liabilities & Stockholders Equity13.46-5.4%14.23+6.5%13.36+21.1%11.03-13.0%12.68+3.8%12.22-3.2%12.63-1.4%12.81-1.6%13.02
Book Value Per Share per share2.44-5.8%2.59+4.4%2.48+22.8%2.02-5.6%2.14-4.9%2.25-2.6%2.31-2.9%2.38-4.0%2.48
Tangible Book Value Per Share per share2.44-5.8%2.59+4.4%2.48+22.8%2.02-5.6%2.14-4.9%2.25-2.6%2.31-2.9%2.38-4.0%2.48
Full-Time Employees people250.0%250.0%25+4.2%240.0%24-4.0%25-10.7%28-3.4%29-6.5%31
Price to Book Ratio ratio3.413.863.114.797.706.388.497.715.70
Return on Assets %15.2123.5621.1721.6737.4226.6037.4533.7027.32
Return on Equity %18.2227.9424.9926.9246.1831.5044.1839.0030.49
Return on Invested Capital %18.7527.3622.6727.7347.4331.9244.7839.8433.73
Quick Ratio ratio6.415.867.196.044.356.957.717.477.39
Current Ratio ratio7.316.627.997.264.957.958.618.558.33

Cash flow, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/2018
Net Income3.132.11-35.1%3.25+26.0%2.58+0.4%2.57-44.8%4.66+41.2%3.30-30.7%4.76+9.4%4.35
Depreciation0.120.11+10.0%0.10-9.1%0.11-21.4%0.14-6.7%0.15-11.8%0.17-5.6%0.18-5.3%0.19
Other Funds (Non Cash)-0.02-0.03-0.04-0.11-110.2%1.08+10700.0%0.01-0.31-0.41-220.6%0.34
Funds from Operations3.572.56-19.5%3.18+20.5%2.64-26.5%3.59-24.4%4.75+62.1%2.93-37.1%4.66-8.8%5.11
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-0.56-0.60-306.9%0.29-43.1%0.51-1.06-289.3%0.56-15.2%0.66-0.18-0.16
Income Taxes Payable---0.00-0.09-200.0%0.09-0.00-0.06
Cash from Operating Activities3.011.97-43.2%3.47+10.5%3.14+24.1%2.53-52.4%5.31+47.9%3.59-19.9%4.48-9.5%4.95
Capital Expenditures-0.07-0.06-0.43-0.17-0.08-0.12-0.04-0.11-0.07
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.010.000.00-100.0%0.01-75.0%0.040.000.000.000.00
Purchase or Sale of Investments0.130.23-6.64-236.1%4.88+419.1%0.94-0.07-0.43-136.1%1.19-0.23
Purchase of Investments-13.22-12.94-8.46-0.62-1.93-4.22-6.80-14.78-8.26
Sale Or Maturity of Investments13.3513.18+628.2%1.81-67.2%5.51+92.0%2.87-30.8%4.15-34.9%6.37-60.1%15.96+99.0%8.02
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities0.070.18-7.08-249.7%4.73+425.6%0.90-0.18-0.47-143.9%1.07-0.31
Cash Dividends Paid-2.53-2.77-2.76-0.46-3.12-5.19-3.58-5.05-4.82
Change in Capital Stock0.000.000.000.000.000.000.000.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.000.00
Cash from Financing Activities-2.53-2.77-2.76-0.46-3.12-5.19-3.58-5.05-4.82
Net Change in Cash0.55-0.62-6.37-186.0%7.41+2370.0%0.30-0.06-0.46-192.0%0.50-0.17
Free Cash Flow2.941.91-37.0%3.03+1.7%2.98+21.6%2.45-52.9%5.20+46.5%3.55-18.6%4.36-10.7%4.88
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow ratio79.77-158.6813.13-10,953.12--1,423.31
Deferred Taxes & Investment Tax Credit-0.38-0.12-300.0%0.06-0.19-0.07-0.24-284.6%0.13-40.9%0.22

Balance sheet, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Cash & Short Term Investments8.74+5.3%9.59+13.9%8.04-1.0%8.57-8.8%8.30-12.6%8.42-14.6%8.12-5.7%9.40+3.4%
Short Term Receivables2.39+106.0%1.69-11.5%2.01+29.7%1.59+11.2%1.16-22.1%1.91+13.7%1.55-27.2%1.43-8.9%
Inventories1.12-20.6%1.18-22.9%1.32-12.0%1.51+4.1%1.41+18.5%1.53+30.8%1.50+17.2%1.45+18.9%
Other Current Assets0.32-13.5%0.25-59.0%0.45-13.5%0.53+35.9%0.37+23.3%0.61+41.9%0.52+26.8%0.39+5.4%
Total Current Assets12.58+11.8%12.71+1.9%11.81+1.0%12.20-3.7%11.25-9.9%12.47-5.1%11.69-6.0%12.67+3.4%
Net Property, Plant & Equipment0.87-5.4%0.88-5.4%0.89-4.3%0.91-5.2%0.92+37.3%0.93+40.9%0.93+50.0%0.96+54.8%
Total Investments and Advances0.000.000.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.000.000.000.00
Deferred Tax Assets---0.35-42.6%0.02-80.0%0.00-100.0%0.140.61+24.5%
Other Assets0.000.000.000.000.000.000.000.00
Total Assets13.45+10.4%13.59+1.5%12.70-0.5%13.46-5.4%12.18-8.1%13.39-3.2%12.76-2.2%14.23+6.5%
Short Term Debt Incl. Current Port. of LT Debt0.000.000.000.000.000.000.000.00
Accounts Payable0.49+104.2%0.50+19.0%0.11-71.1%0.48+11.6%0.24-52.9%0.42+23.5%0.38-9.5%0.43+230.8%
Other Current Liabilities1.45+7.4%1.24-13.9%1.35-12.9%1.19-20.1%1.35-0.7%1.44+4.3%1.55+7.6%1.49+6.4%
Total Current Liabilities1.94+21.2%1.74-5.9%1.47-23.8%1.67-12.6%1.60-14.9%1.85+8.2%1.93+3.8%1.91+24.8%
Long Term Debt0.000.000.000.000.000.000.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.00
Deferred Tax Liabilities0.330.22+175.0%0.330.56+27.3%-0.08-0.440.0%
Other Liabilities0.000.000.000.000.000.000.000.00
Total Liabilities2.26+41.2%1.96+1.6%1.80-6.7%2.23-5.1%1.60-14.9%1.93+12.9%1.93+2.7%2.35+19.3%
Non-Equity Reserves0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.00
Common Equity11.18+5.7%11.63+1.5%10.90+0.6%11.23-5.5%10.58-7.0%11.46-5.4%10.84-3.0%11.88+4.3%
Total Shareholders Equity11.18+5.7%11.63+1.5%10.90+0.6%11.23-5.5%10.58-7.0%11.46-5.4%10.84-3.0%11.88+4.3%
Accumulated Minority Interest0.000.000.000.000.000.000.000.00
Total Equity11.18+5.7%11.63+1.5%10.90+0.6%11.23-5.5%10.58-7.0%11.46-5.4%10.84-3.0%11.88+4.3%
Total Liabilities & Stockholders Equity13.45+10.4%13.59+1.5%12.70-0.5%13.46-5.4%12.18-8.1%13.39-3.2%12.76-2.2%14.23+6.5%
Book Value Per Share per share2.43+5.7%2.53+1.6%2.37+0.4%2.44-5.8%2.30-7.3%2.49-5.7%2.36-2.9%2.59+4.4%
Tangible Book Value Per Share per share2.43+5.7%2.53+1.6%2.37+0.4%2.44-5.8%2.30-7.3%2.49-5.7%2.36-2.9%2.59+4.4%
Full-Time Employees people---250.0%---250.0%
Price to Book Ratio ratio3.413.012.742.673.153.393.483.86
Return on Assets %24.4118.2718.5715.2115.4118.7822.3723.56
Return on Equity %28.7421.3521.7518.2217.8521.6826.2427.94
Return on Invested Capital %8.326.267.515.782.545.475.184.24
Quick Ratio ratio5.926.647.156.416.165.905.295.86
Current Ratio ratio6.507.328.057.317.046.736.076.62

Cash flow, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Net Income0.93+244.4%0.73+15.9%0.82+46.4%0.65+30.0%0.27-69.0%0.63-34.4%0.56-39.8%0.50-32.4%
Depreciation0.030.0%0.030.0%0.030.0%0.030.0%0.03+50.0%0.03+50.0%0.03+50.0%0.030.0%
Other Funds (Non Cash)0.02-0.06-0.020.04-33.3%-0.04-0.02-0.010.06
Funds from Operations1.08+575.0%0.59-30.6%0.95+55.7%0.95+86.3%0.16-79.2%0.85-8.6%0.61-37.1%0.51-13.6%
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital-0.52-160.5%0.93-0.35-0.620.86+87.0%-0.54-235.0%-0.29-0.24-144.4%
Cash from Operating Activities0.55-45.5%1.52+406.7%0.60+87.5%0.33+22.2%1.01-17.9%0.30-77.3%0.32-50.0%0.27-76.1%
Capital Expenditures-0.02-0.02-0.01-0.02-0.02-0.02-0.00-0.32
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.010.000.000.000.000.000.00
Purchase or Sale of Investments-0.140.15-31.8%0.04-94.1%0.08-0.750.22+214.3%0.68-0.52-677.8%
Purchase of Investments-5.94-0.54-5.95-0.80-5.75-0.93-5.47-1.27
Sale Or Maturity of Investments5.79+16.0%0.69-40.0%5.99-2.6%0.88+17.3%4.99+1620.7%1.15+85.5%6.15+4000.0%0.75+200.0%
Other Uses0.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.00
Cash from Investing Activities-0.160.13-38.1%0.03-95.6%0.06-0.770.21+2000.0%0.68-0.84
Cash Dividends Paid-1.380.00-1.150.00-1.15-0.01-1.610.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.000.000.00
Change in Capital Stock0.000.000.000.000.000.000.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.00
Cash from Financing Activities-1.380.00-1.150.00-1.15-0.01-1.610.00
Net Change in Cash-0.981.65+230.0%-0.520.39-0.910.50-62.4%-0.61-0.57-150.4%
Free Cash Flow0.54-46.0%1.50+417.2%0.59+84.4%0.311.00-16.7%0.29-77.0%0.32-48.4%-0.05-104.9%
Price to Free Cash Flow ratio79.7729.80-----158.68

Revenue breakdown

USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.

Product
Name20242025vs 20242025 share
Cosmetic Ingredients5.443.01-44.7%28.5%
Medical Lubricants2.032.11+4.1%20.0%
Pharmaceuticals4.725.43+15.1%51.5%
Total12.1810.55-13.4%100.0%
Region
Name20242025vs 20242025 share
Non-US2.012.40+19.8%22.8%
United States10.188.14-20.0%77.2%
Total12.1810.55-13.4%100.0%

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-300.29%0.0M3.0M9.22K
2026-10-150.26%0.0M3.0M10.37K
2026-09-300.42%0.0M3.0M8.80K
2026-09-150.67%0.0M3.0M8.53K
2026-08-310.54%0.0M3.0M7.90K
2026-08-140.39%0.0M3.0M7.49K
2026-07-310.21%0.0M3.0M7.28K
2026-07-150.31%0.0M3.0M5.37K
2026-06-300.37%0.0M3.0M5.04K
2026-06-150.25%0.0M3.0M5.04K
2026-05-290.33%0.0M3.0M4.60K
2026-05-150.33%0.0M3.0M4.70K
2026-04-300.37%0.0M3.0M6.58K
2026-04-150.43%0.0M3.0M7.76K
2026-03-310.43%0.0M3.0M8.35K
2026-03-130.27%0.0M3.0M10.14K
2026-02-270.22%0.0M3.0M11.45K
2026-02-130.25%0.0M3.0M13.45K
2026-01-300.27%0.0M3.0M12.12K
2026-01-150.23%0.0M3.0M10.89K

Option chain

Expiry 2026-11-13 · underlying 8.63, quoted 12 Nov 15:59 ET · ATM -

Option quotes -. A date on a row is older than the last session (12 Nov). 0 rows.

Implied move — the ATM straddle is not quoted.

Put/call open interest — no calls · Put/call volume — no calls

IV change is points against the prior close.

TypeStrikeMoneyBidAskLastChgIVOpen intVolumeLast sizeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30 of 201
AllAll annual, quarterly, and current reportsInsider equity awards, transactions, and ownership (Section 16 Reports)Beneficial ownership reportsExempt offeringsRegistration statements and prospectusesFiling review correspondenceSEC orders and noticesProxy materialsTender offers and going private transactionsTrust indenture filings

10-Q filed 2026-11-12, period ended 2026-09-30. 10-K filed 2026-03-27, period ended 2025-12-31. UG on EDGAR

page 1 of 7Next →
FiledFormDescriptionPeriodDocument
2026-11-1210-QAll annual, quarterly, and current reports2026-09-300001171843-26-007381 index
2026-11-098-KAll annual, quarterly, and current reports2026-11-090001171843-26-007262 index
2026-08-1110-QAll annual, quarterly, and current reports2026-06-300001171843-26-005409 index
2026-08-078-KAll annual, quarterly, and current reports2026-08-070001171843-26-005349 index
2026-07-168-KAll annual, quarterly, and current reports2026-07-160001171843-26-004713 index
2026-05-158-KAll annual, quarterly, and current reports2026-05-130001171843-26-003455 index
2026-05-1210-QAll annual, quarterly, and current reports2026-03-310001171843-26-003276 index
2026-05-088-KAll annual, quarterly, and current reports2026-05-080001171843-26-003193 index
2026-04-22ARSProxy materials2025-12-310001171843-26-002645 index
2026-04-06DEF 14AProxy materials2026-05-130001171843-26-002251 index
2026-03-2710-KAll annual, quarterly, and current reports2025-12-310001171843-26-001973 index
2026-03-278-KAll annual, quarterly, and current reports2026-03-270001171843-26-001972 index
2026-01-298-KAll annual, quarterly, and current reports2026-01-290001171843-26-000508 index
2026-01-234Insider equity awards, transactions, and ownership (Section 16 Reports)2026-01-21 · transaction0000943504-26-000001 index
2025-11-0610-QAll annual, quarterly, and current reports2025-09-300001171843-25-007077 index
2025-11-068-KAll annual, quarterly, and current reports2025-11-060001171843-25-007076 index
2025-08-0810-QAll annual, quarterly, and current reports2025-06-300001171843-25-005207 index
2025-08-088-KAll annual, quarterly, and current reports2025-08-080001171843-25-005206 index
2025-07-158-KAll annual, quarterly, and current reports2025-07-150001171843-25-004466 index
2025-05-218-KAll annual, quarterly, and current reports2025-05-150001171843-25-003368 index
2025-05-168-KAll annual, quarterly, and current reports2025-05-150001171843-25-003275 index
2025-05-1310-QAll annual, quarterly, and current reports2025-03-310001171843-25-003113 index
2025-05-088-KAll annual, quarterly, and current reports2025-05-080001171843-25-002955 index
2025-04-15ARSProxy materials2024-12-310001171843-25-002206 index
2025-04-07DEF 14AProxy materials2025-05-150001171843-25-002058 index
2025-03-2110-KAll annual, quarterly, and current reports2024-12-310001171843-25-001611 index
2025-03-218-KAll annual, quarterly, and current reports2025-03-210001171843-25-001610 index
2025-01-308-KAll annual, quarterly, and current reports2025-01-300001171843-25-000528 index
2024-11-1210-QAll annual, quarterly, and current reports2024-09-300001171843-24-006259 index
2024-11-088-KAll annual, quarterly, and current reports2024-11-080001171843-24-006160 index

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
GAMCO INVESTORS, INC. ET AL3.58%
VANGUARD CAPITAL MANAGEMENT LLC2.79%
RENAISSANCE TECHNOLOGIES LLC2.38%
DIMENSIONAL FUND ADVISORS LP1.56%
Rodgers Brothers Inc.1.30%
Teton Advisors, LLC1.17%
PARTHENON LLC1.10%
GABELLI FUNDS LLC0.83%
GEODE CAPITAL MANAGEMENT, LLC0.77%
UNITED CAPITAL FINANCIAL ADVISORS, LLC0.44%

Funds

Fund% owned
1290 VT GAMCO Small Company Value Portfolio3.41%
VANGUARD TOTAL STOCK MARKET INDEX FUND1.96%
TETON Westwood Mighty Mites Fund1.17%
The Gabelli Small Cap Growth Fund0.83%
VANGUARD EXTENDED MARKET INDEX FUND0.78%
U.S. MICRO CAP PORTFOLIO0.70%
Fidelity Extended Market Index Fund0.37%
iShares Micro-Cap ETF0.24%
Dimensional U.S. Small Cap ETF0.23%
Ultra-Small Company Market Fund0.18%

OakChart. UG. Cached 15 minutes. Terms

Some panels did not load: ratings, insider.